As Covid-19 cases rise, testing in 4 most affected cities slowing

Better testing is key to identifying new areas of the surge before they turn into hotspots.

Mumbai, coronavirus, tests, covid
A health worker testing for Covid-19 collects the swab sample of a passenger at the Bandra Terminus railway station in Mumbai on December 16, 2021. (PTI Photo/Kunal Patil)
BS Data Team Pune
1 min read Last Updated : Dec 29 2021 | 12:28 PM IST
Scientists and doctors know more about Omicron a month after it was declared a coronavirus variant of concern and rapidly spreads across the world and Indian cities.

Test positivity rate--the percentage of all coronavirus tests that turn out to be positive --is rising in Mumbai, Pune, Delhi and Bengaluru, four of the most-affected cities. Here, weekly averages of confirmed cases and laboratory tests have been used to arrive at a weekly test positivity rate, which refers to the seven days prior to any particular date.

Mumbai, Delhi and Pune have shown a dramatic rise in the positivity rate in the most recent weeks. The uptick in Bengaluru seems to be a bit gradual, for now.


Mumbai's weekly test positivity rate (averaged) has risen from a steady cling to 0.5 per cent in the first two weeks of December, to 1.58 per cent in the seven days ending 27 December. (The daily test positivity rate has crossed 2 per cent). Pune, which showed a high test positivity rate even in the period of low Covid-19 spread, has seen positivity increase from levels of 1.3 per cent to 1.6 per cent.

The positivity rate in Delhi was below 0.1 per cent until December 1, but has since risen to 0.4 per cent. The positivity rate has more than doubled in the last week. The number of infections during this period has nearly doubled. On the other hand, the rise in positivity rate in Bengaluru has been slower than Delhi. The positivity rate in the tech capital has risen from 0.4 per cent to 0.6 per cent.

This should naturally nudge the civic administrations to ramp up testing, targeted in localities or wards where the positivity rate is rising fast.

Early December, the four cities did ramp up testing. This could have been in response to the spread of Omicron through international travel, and increased testing and airports coupled with contact tracing. But in the second fortnight of December, testing has dropped.

Except Pune, the three other cities show a clear drop in testing in the days close to Christmas and as 2021 draws to an end.



Delhi has been averaging 56,000 tests daily, at a rate of close to 3,000 tests per million per day. The testing rate has not increased as such. Mumbai, which went from 2,300 tests per million per day to close to 3,000, has fallen back to 2,800 tests per million per day in recent days. Weekly average of tests is used here.

Pune's testing is weaker than the three metros though the Maharashtra city appears to have scaled up in recent weeks. Testing rates in the country as a whole are in the range of 800-850 tests per million per day.

Better testing holds key to identifying new areas of the surge before they turn into hotspots.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusCoronavirus TestsCoronavirus Vaccine

Next Story